Is the RPA market in trouble?

Is the RPA market in trouble?

Automation Anywhere, one of the best-funded RPA providers with over $1 billion capital raised to date, went the debt route this week, securing a $200 million loan from Silicon Valley Bank, SVB Capital and Hercules Capital.

As a result, some Klonopin Legally patients may find themselves Ambien Cheap inadequately informed about their treatment options. The ongoing conversation about sleep hygiene, the sleep-wake cycle, and sleep continuity has garnered attention in the Buy Ambien Online Without Prescription US, emphasizing the need for comprehensive strategies that support healthier sleep practices. Incorporating lifestyle changes, such as physical activity and nutrition, into treatment plans has also Order Clonazepam Online emerged as a significant focus. For instance, individuals with Ambien Cheap congenital muscular dystrophy often present unique challenges. Sharing personal Zolpidem Without A Prescription stories can help individuals feel less isolated and more empowered to advocate for their needs within the healthcare system. Patients who participate in Tramadol No Rx support groups or have an understanding social circle often report better pain management outcomes. A well-balanced diet How To Buy Xanax Online can provide the energy needed for physical activity and support overall health. Physicians and nutritionists Ambien No Prescription often work together to create tailored dietary plans aimed Order Ativan Online at reducing the frequency of vomiting episodes. For instance, individuals suffering from test anxiety often report headaches, gastrointestinal issues, Best place to Buy Tramadol Online and muscle pain, which can be Zopiclone Overnight Delivery debilitating during crucial performance moments.

Debt raises aren’t necessarily a bad thing — they’re a useful tool, particularly for companies with high annual recurring revenue — but the magnitude and timing of the Automation Anywhere raise suggests it was more out of necessity than choice.

“This new financing will provide operational capital for the next several years as Automation Anywhere continues to advance its cloud-native automation platform,” CEO Mihir Shukla told TechCrunch via email. “We’re using AI and intelligent automation to design tech that’s accessible to everyone — all kinds of business leaders, managers and citizen developers.”

While Shukla insists Automation Anywhere’s business is robust, with a customer base of around 5,000 and “over 50% revenue growth,” the RPA market has long faced headwinds as investors increasingly express skepticism that the technology, which automates repetitive software tasks at enterprise scale, can deliver on its many promises.

PitchBook notes that shares of UiPath — Automation Anywhere’s main rival, which went public in April 2021 — plummeted 71% this year. Meanwhile, another large player, Blue Prism, last September agreed to sell itself to Vista Equity Partners for £1.095 billion (about $1.5 billion).

Gartner predicts that while the RPA market will reach $2.9 billion by the beginning of 2023, the growth rate will end substantially lower than it was in 2021, when the segment expanded by 30.9% compared to the year prior. Assuming the $2.9 billion figure comes to pass, it’d translate to 19.5% growth between the years 2021 and 2022.

Source @TechCrunch

Leave a Reply